Maypro and HITLAB form partnership to harness digital health solutions to enhance products and services
According to the company’s press release, the collaboration will involve multiple aspects of digital technology, including novel ingredient discovery, formulation optimization, personalized care, and efficient clinical trial processes.
Photo © AdobeStock.com/Tom
Maypro (Purchase, NY) has announced a partnership with HITLAB that combines the company’s expertise in nutraceuticals with HITLAB’s to leverage digital technology and AI to create a discovery launchpad that enhances the Maypro’s B2B and DTC wellness products and services. According to the company’s press release, the collaboration will involve multiple aspects of digital technology, including novel ingredient discovery, formulation optimization, personalized care, and efficient clinical trial processes.
“In today’s rapidly evolving digital landscape, our collaboration with HITLAB represents an exciting opportunity to harness technology’s transformative power in the pursuit of wellness,” said May Yamada-Lifton, CEO of Maypro Group, in a press release. “Together, we want to think of how to play in the greater wellness space and create a digitally dynamic company.”
An initial focus, says Maypro, will be to understand on how digital health solutions may help brands, consumers, and doctors be more educated on the nutritional needs of individuals as well as specific populations, and use this info to better address their needs.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
